The medicine may be given with or without food, depending on the doctor's instructions
If youve completed a month at your current dose, tolerate it well, and are experiencing a plateau despite consistent habits, it may be time to talk with a clinician about your next step
This medication is designed for adults with obesity or those who are overweight and have at least one weight-related health condition
In this sense, several authors have already reported a positive influence of DPP-4 inhibitors and GLP-1 on pancreatic tissue in the T2DM model, either by proliferation/maintenance of functional beta cells, inhibition of apoptosis or pancreatic islet neogenesis 9,45
Her symptoms lasted for three days, and she restarted her medication a week after the last dose and did not have any other problems
Comprehensive medical evaluation before starting any GLP-1 agonist is the standard of care